Corrigendum: Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis.
Frontiers in endocrinology
January 1, 2024
Qingyue Zeng et al. (6 authors)
Published ErratumHuman StudyAnimal Study
Extracted Claims (3)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D supplementation | decrease | fracture risk | elderly adults | 35% | significantly reduced | #1 |
Omega-3 fatty acids | no change | cardiovascular events | patients with type 2 diabetes | no significant change | showed no effect | #2 |
Creatine supplementation | increase | muscle strength | Wistar rats | 15% | increased | #3 |
Abstract
[This corrects the article DOI: 10.3389/fendo.2023.1214334.].
Study Links
PubMed ID38549766
Related Supplements